Please login to the form below

Not currently logged in
Email:
Password:

government strategy

This page shows the latest government strategy news and features for those working in and with pharma, biotech and healthcare.

Medical AI gets £50m boost and five new centres in UK

Medical AI gets £50m boost and five new centres in UK

AI is one of the one of four ‘Grand Challenges’in the UK government’s industrial strategy, and the country has become a hot spot for AI in healthcare, home to ... Digital inspiration for pharma on mobile, social media, strategy, best practice,

Latest news

More from news
Approximately 11 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Nevertheless, Osbourn said it is encouraged by the government’s commitment to an industrial strategy that safeguards life sciences.

  • 30 Women Leaders in UK Healthcare

    ecosystem. MSD’s expansion over the coming years will help the company hold the government to its promises included in the Life Sciences Sector Deal. ... Louise was also involved in the launch of the government’s Industrial Strategy last year, which

  • Lighting the way Lighting the way

    That new industrial strategy (see p7) hands a prominent role to life sciences, naming it as the first of 10 strategic pillars that will be leant upon to support the ... She noted that engaging with the government on the new Life Sciences Strategy (see p7)

  • Bringing about digital health change Bringing about digital health change

    Regulators are not a problem, Valencia states, and providers - such as the NHS - have shown openness to change, which is enshrined in the UK government's Five Year Forward strategy. “ ... Digital inspiration for pharma on mobile, social media, strategy,

  • Russian innovation at the crossroads Russian innovation at the crossroads

    The government came up with a strategy to develop high technology sectors such as pharmaceuticals, electronics, nanotechnology and others. ... During the first three years of Strategy's implementation (2011-2013), the key objective for the government was

More from intelligence
Approximately 3 fully matching, plus 7 partially matching documents found.

Latest appointments

  • IFPMA appoints Fumie Griego as assistant director general IFPMA appoints Fumie Griego as assistant director general

    She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    She brings further pharmaceutical management experience from California-based Salick Health Care, where she was vice president of strategy, and management consultancy expertise from KPMG. ... Lisa will play a leading role as we negotiate the future of

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    Jeffrey Winton, senior vice president of corporate affairs at Astellas, said: “ Joe's experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals ... His role in

  • Astellas adds to US comms team Astellas adds to US comms team

    Astellas continued to strengthen its communication and public affairs efforts in the US with the appointment of Marty Golden as VP, government affairs. ... In this role, Golden will lead federal government affairs, state government affairs, therapeutic

  • Sir Tom Blundell to remain as chair of UK’s biotech research council Sir Tom Blundell to remain as chair of UK’s biotech research council

    Reappointed to government role to support research. Sir Tom Blundell has been reappointed as chair of the UK's Biotechnology and Biological Sciences Research Council (BBSRC), a government-funded organisation to

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government

    What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government. ... Assessing the impact of a Corbyn-led Labour government’. GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘ What Would Jeremy Do?

  • Shining a light on the true cost of patient care

    When Sir John Bell recently published his recommendations for the Life Sciences strand of the Government’ s Industrial Strategy, he said that the NHS’ s structure gives it data sharing opportunities ... However, before this can happen, the Government

  • Getting to grips with Russia’s healthcare market

    Increasing GDP, rising consumer incomes and government strategy to transform the nation’ s healthcare are the key growth drivers. ... national Vital and Essential Drug list, making inclusion on this more importantand reducing the importance of a

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics